Skip to main content
. 2021 Jan 29;2021(1):CD013496. doi: 10.1002/14651858.CD013496.pub2

NCT04062773.

Study name Time‐restricted feeding on glucose homeostasis and quality of life
Methods 12 wk Randomised controlled trial
Participants 50 participants. Ages Eligible for Study: 21 years to 65 years (adult, older adult)
Sexes Eligible for Study: all
Accepts Healthy volunteers: no

Inclusion Criteria
Must agree to follow time restricted feeding protocol if randomised to the TRF arm.
Age 21‐65 years
T2DM with any diabetes medication
BMI of 25‐45 kg/m2
Wake up at a regular time between 5 am to 8 am
Able to provide informed consent.
Interventions Arm Intervention/treatment
Experimental: TRF
Eating restricted to between midday and 6 pm.
Behavioural: TRF
Time restricted feeding group
Placebo comparator: normal timing of food intake.
Eating between 8 am and 11 pm.
Behavioural: Normal timing of food intake
No time restricted feeding
Outcomes Primary Outcome Measures :
HbA1c [ Time Frame: 12 weeks ]
Change in HbA1c between the intervention and control arms.
Secondary Outcome Measures:
Body weight [ Time Frame: 12 weeks ]
Change in body weight between the intervention and control arms.
Insulin sensitivity [ Time Frame: 12 weeks ]
Change insulin sensitivity assessed by OGTT between the intervention and control arms.
Diabetes medications [ Time Frame: 12 weeks ]
Change in diabetes medications between the intervention and control arms.
Inflammatory markers [ Time Frame: 12 weeks ]
Change in TNF‐alpha in pg/mL between the intervention and control arms.
Inflammatory markers [ Time Frame: 12 weeks ]
Change in IL‐10 in pg/mL between the intervention and control arms.
Inflammatory markers [ Time Frame: 12 weeks ]
Change in IL‐6 in pg/mL between the intervention and control arms.
Inflammatory markers [ Time Frame: 12 weeks ]
Change in IL‐18 in pg/mL between the intervention and control arms.
Inflammatory markers [ Time Frame: 12 weeks ]
Change in CRP in mg/L between the intervention and control arms.
Inflammatory markers [ Time Frame: 12 weeks ]
Change in adiponectin in µg/mL the intervention and control arms.
Starting date July 10, 2019
Contact information Nicola.Guess@dasmaninstitute.org
Notes NCT04062773